It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.


Cost shouldn’t be an obstacle on your growth hormone treatment journey

For patients without insurance, or who wish to pay in cash to skip the reimbursement process and begin growth hormone treatment as soon as possible, cost-saving options are available to help you save thousands per year.

Omni SPP


Eligible* patients may save an average of over $5,000 per year, vs wholesale acquisition cost.

The Omnitrope Self Pay Program is the most comprehensive among daily somatropin injections because it accounts for 2 formulation options to meet your needs.
 

Drop Bar@1.5x


Take a look at our full price breakdown

Omnitrope vial and syringe.

Omnitrope
Vial and Syringe

First fill: $17.50/mg
Subsequent fills: $17.50/mg

Using a vial and syringe is the more cost-effective administration option for Omnitrope. If you choose the vial and syringe option, an OmniSource® Nurse Trainer will teach you how to safely mix your medication at home.

Omnitrope Pen 5/10

First fill: $20/mg
Subsequent fills: $22/mg

Omnitrope injection pens may be a good option if you or your child is uncomfortable around traditional needles. The pen may also be a convenient choice if you would prefer not to mix your growth hormone medication at home.

In the photo, two foams for injection of the drug Omnitrope.

Not sure about which formulation option to choose? Your OmniSource Case Manager can help you decide, based on your lifestyle and the dose your doctor has prescribed.

 

OmniSource_4c_full colour

To get started with the Self Pay Program,
call Omnisource today

877-456-6794

Monday – Friday, 8 AM – 8 PM ET

Chrome-rail-Thin 1@1.5x

*Omnitrope Self Pay Program: Prescriptions must be for an approved indication. This program is not health insurance. Patients are not eligible if this prescription is paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, TRICARE, private indemnity, or HMO insurance plans that reimburse you for the entire cost of Omnitrope, or where prohibited by law. Patients with a state-or federally funded program that does not cover any of the cost for their Omnitrope prescription are eligible to participate. Patients may continue to participate as long as they meet the eligibility criteria. Omnitrope Self Pay Program may not be combined with any other rebate, coupon, or offer. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.

Questions about Omnitrope?

FAQs

To learn more about Omnitrope and our comprehensive patient support services, see our FAQ page for frequently asked questions about Omnitrope.

 

Read FAQs

Contact Us

You can also call our OmniSource team at the number below. We can walk you through the process of getting started with Omnitrope.

Available: Monday – Friday, 8AM – 8PM ET

Phone: 877-456-6794

 

Indications and Important Safety Information

Indications
Omnitrope is a prescription medicine that contains human growth hormone and is used to treat:

  • Children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age, Turner Syndrome, and Idiopathic Short Stature
  • Adults with either adult onset or childhood onset GHD

IMPORTANT SAFETY INFORMATION

Who should not take Omnitrope®?

Omnitrope should not be used by children or adults that have:

  • a critical illness caused by certain types of heart or stomach surgery, accidental trauma, or a sudden and severe breathing problem (respiratory failure)
  • Prader-Willi syndrome who are severely overweight or have a history of breathing problems including sleep apnea
  • cancer or other tumors
  • allergies to growth hormone or any of the ingredients in the medicine
  • certain types of eye problems caused by diabetes
  • closed bone growth plates

What should patients tell their healthcare provider before taking Omnitrope?

Patients should tell their healthcare provider about all of their medical conditions, including if they: 

  • have had heart or stomach surgery, trauma, or serious breathing
    problems
  • have or have had cancer or any tumor
  • have diabetes
  • take any prescription and non-prescription medicines, steroids, vitamins, or herbal supplements
  • are pregnant or breastfeeding, or plan to become pregnant or
    breastfeed 

What are the most common side effects of Omnitrope?

  • local reactions at the injection site (such as pain, numbness,
    redness and swelling)
  • headaches
  • swelling associated with fluid retention
  • pain in joints and muscle pain
  • carpal tunnel syndrome
  • tingling and numbness
  • high blood sugar (hyperglycemia/diabetes) and sugar in your urine
    (glucosuria)
  • unusual skin sensations
  • low levels of thyroid hormone (hypothyroidism)

Other possible side effects of Omnitrope are:

  • return of tumor or cancerous growths
  • headaches, changes in vision, nausea or vomiting (these may be
    symptoms of raised pressure in the brain which requires immediate
    medical attention)
  • hip and knee pain or a limp in children, that can be a sign of
    slipped capital femoral epiphysis
  • worsening of pre-existing curvature of the spine in children
    (scoliosis)
  • increased ear infections and ear disorders in children with Turner
    syndrome; check for cardiovascular disorders (hypertension,
    stroke)
  • intense pain and tenderness in the abdomen as consequence of an
    inflammation of the pancreas (pancreatitis)
  • gasping syndrome (decreased rate of breathing) in children from
    high levels of benzyl alcohol (an inactive ingredient)
  • Increased mortality in patients with Prader Willi and acute illness

Please see full Prescribing Information for Omnitrope.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.